Djajawi TM, Huber A, Rivera SM, Srivaths A, Salehi M, Gunay G, Gerak C, Neil L, Ozaydin O, Voulgaris O, Al Halawani A, Gannon D, Khoshdoozmasouleh N, Jenkins LJ, Chan KF, Behren A, Ernst M, Mielke LA, Lelliott EJ, Dong H, Feltham R, Sutton VR, Trapani JA, Mariadason JM, Pal B, Martin SJ, Vervoort SJ, Kearney CJ. A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity. Cell Reports. 2025;:10.1016/j.celrep.2025.116665
Huber A, Djajawi TM, Rivera IS, Vervoort SJ, Kearney CJ. CRISPR screens define unified hallmarks of cancer cell-autonomous immune evasion. Cell Reports. 2025;45(1):10.1016/j.celrep.2025.116738
Bao Y, Cacioppo R, Crisp A, Shlamovitz I, Sale JE, Vidakovic AT, Vervoort SJ, Zeller A. Protocol for double-crosslinking ChIP-seq to improve data quality and enhance detection of challenging chromatin targets. STAR Protocols. 2025;6(4):10.1016/j.xpro.2025.104171
Devlin JR, Martin B, Bartonicek N, Ting K, Fan Z, Todorovski I, Bjelosevic F, Verschoor S, Ciccone A, Trapani JA, Horvath A, Tinsley E, Fraser P, Newbold A, Sandow JJ, Muscat A, Simpson KJ, Geyer M, Vervoort SJ, Johnstone RW. A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation. Molecular Cell. 2025;85(17):10.1016/j.molcel.2025.08.001
Tan W, Park J, Venugopal H, Lou J, Dias PS, Baldoni PL, Moon K-W, Dite TA, Keenan CR, Gurzau AD, Lee J, Johanson TM, Leis A, Yousef J, Vaibhav V, Dagley LF, Ang C-S, Corso LD, Davidovich C, Vervoort SJ, Smyth GK, Blewitt ME, Allan RS, Hinde E, D’Arcy S, Ryu J-K, Shakeel S. MORC2 is a phosphorylation-dependent DNA compaction machine. Nature Communications. 2025;16(1):10.1038/s41467-025-60751-z
Fidelito G, Todorovski I, Cluse L, Vervoort SJ, Taylor RA, Watt MJ. Lipid-metabolism-focused CRISPR screens identify enzymes of the mevalonate pathway as essential for prostate cancer growth. Cell Reports. 2025;44(4):10.1016/j.celrep.2025.115470
Lelliott EJ, Naddaf J, Ganio K, Michie J, Wang S, Liu L, Silke N, Ahn A, Ramsbottom KM, Brennan AJ, Freeman AJ, Goel S, Vervoort SJ, Kearney CJ, Beavis PA, McDevitt CA, Silke J, Oliaro J. Intracellular zinc protects tumours from T cell-mediated cytotoxicity. Cell Death & Differentiation. 2024;31(12):10.1038/s41418-024-01369-4
Costacurta M, Sandow JJ, Maher B, Susanto O, Vervoort SJ, Devlin JR, Garama D, Condina MR, Steele JR, Kahrood HV, Gough D, Johnstone RW, Shortt J. Mapping the IMiD‐dependent cereblon interactome using BioID‐proximity labelling. The FEBS Journal. 2024;291(22):10.1111/febs.17196
Todorovski I, Tsang M-J, Feran B, Fan Z, Gadipally S, Yoannidis D, Kong IY, Bjelosevic S, Rivera S, Voulgaris O, Zethoven M, Hawkins ED, Simpson KJ, Arnau GM, Papenfuss AT, Johnstone RW, Vervoort SJ. RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines. NAR Cancer. 2024;6(4):10.1093/narcan/zcae039
Djajawi TM, Wichmann J, Vervoort SJ, Kearney CJ. Tumor immune evasion: insights from CRISPR screens and future directions. The FEBS Journal. 2024;291(7):10.1111/febs.17003
